American Alpha Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$679K Sell
5,641
-411
-7% -$47.5K 0.36% 47
2025
Q4
$637K Buy
6,052
+766
+14% +$71.9K 0.38% 46
2025
Q3
$444K Sell
5,286
-305
-5% -$25.1K 0.31% 55
2025
Q2
$443K Buy
5,591
+913
+20% +$72.6K 0.35% 53
2025
Q1
$420K Buy
+4,678
New +$437K 0.35% 55

Other funds holding MRK

American Alpha Advisors's MRK Position: Q1 2026 in Review

American Alpha Advisors reduced its Merck (MRK) stake by 6.8% in Q1 2026, selling an estimated $47.5K and leaving 5,641 shares worth $679K. The position accounts for 0.36% of the portfolio, ranked #47.

American Alpha Advisors first reported a position in MRK in Q1 2025 and has held it in 5 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • American Alpha Advisors held 5,641 shares of Merck worth $679K as of Q1 2026.
  • American Alpha Advisors sold 411 Merck shares in Q1 2026, an estimated $47.5K.
  • Merck made up 0.36% of American Alpha Advisors's portfolio in Q1 2026, its #47 holding.
  • American Alpha Advisors first reported a position in Merck in Q1 2025 and has held it in 5 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on American Alpha Advisors's 13F filing for Q1 2026, filed 15 May 2026.